{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-002669","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.165103+00:00","generated_at":"2026-06-02T08:35:10.862059+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cassava Sciences raises over $125M from warrant exercises; ~5.7M shares at $22","bullets":["Gross proceeds over $125M from cash exercises of warrants; ~5.7M common shares issued at $22.00 per share.","Net proceeds estimated at over $123M after advisory fees and expenses.","Proceeds to fund working capital and continued development of Alzheimer's drug simufilam.","Warrants distributed to shareholders, last exercise deadline May 6, 2024; remaining warrants redeemed at $0.001 each.","B. Dyson Capital Advisors acted as exclusive financial advisor on the warrant distribution."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-002669","json":"https://secwatch.observer/filing/0001171843-24-002669.json","markdown":"https://secwatch.observer/filing/0001171843-24-002669.md","text":"https://secwatch.observer/filing/0001171843-24-002669.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/0001171843-24-002669-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/f8k_050824.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T08:35:10.862059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}